Citation: Mg. Korman et al., SUCRALFATE AS AN ALTERNATIVE TO BISMUTH IN QUADRUPLE THERAPY FOR HELICOBACTER-PYLORI ERADICATION, Helicobacter, 2(3), 1997, pp. 140-143
Citation: Td. Bolin et Mg. Korman, HOW CAN WE REDUCE THE INCIDENCE AND MORTALITY OF COLORECTAL-CANCER, Medical journal of Australia, 167(4), 1997, pp. 227-228
Citation: Td. Bolin et Mg. Korman, HOW CAN WE REDUCE THE INCIDENCE AND MORTALITY OF COLORECTAL-CANCER, Medical journal of Australia, 166(4), 1997, pp. 175-176
Citation: Td. Bolin et al., LANSOPRAZOLE AND BISMUTH TRIPLE THERAPY IN THE ERADICATION OF HELICOBACTER-PYLORI, Gastroenterology, 112(4), 1997, pp. 76-76
Citation: Fb. Nicholson et al., SUCRALFATE - AN EFFECTIVE ALTERNATIVE TO H-2-RECEPTOR ANTAGONISTS IN MILD REFLUX ESOPHAGITIS, Gastroenterology, 112(4), 1997, pp. 236-236
Authors:
IRVINE EJ
BOLIN T
GRACE E
KERR GD
KORMAN MG
LYRENAS E
OMORAIN C
Citation: Ej. Irvine et al., GEOGRAPHIC DIFFERENCES IN HEALTH-RELATED QUALITY-OF-LIFE (HRQOL) IN INFLAMMATORY BOWEL-DISEASE (IBD), Gastroenterology, 112(4), 1997, pp. 1003-1003
Citation: Mg. Korman, HELICOBACTER-PYLORI ERADICATION - THERAPY OTHER THAN WITH BISMUTH OR PROTON-PUMP INHIBITORS, Scandinavian journal of gastroenterology, 31, 1996, pp. 41-43
Citation: Mg. Korman et al., QUADRUPLE THERAPY IN HELICOBACTER-PYLORI ERADICATION USING OMEPRAZOLE, SUCRALFATE, TETRACYCLINE AND METRONIDAZOLE, Gastroenterology, 110(4), 1996, pp. 161-161
Authors:
LIN SK
LAMBERT JR
SCHEMBRI MA
NICHOLSON L
KORMAN MG
Citation: Sk. Lin et al., HELICOBACTER-PYLORI PREVALENCE IN ENDOSCOPY AND MEDICAL STAFF, Journal of gastroenterology and hepatology, 9(4), 1994, pp. 319-324
Citation: N. Onishi et al., GASTRIC ADENOCARCINOMA - ASSOCIATION OF GASTRITIS AND INTESTINAL METAPLASIA AND HELICOBACTER-PYLORI, Gastroenterology, 106(4), 1994, pp. 10000152-10000152